Skip to content

Pleural Effusion Following Cardiac Surgery: Prevalence, Risk Factors and Clinical Features

Pleural Effusions Following Cardiac Surgery: Prevalence, Risk Factors and Clinical Features.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00665015
Enrollment
2892
Registered
2008-04-23
Start date
2004-01-31
Completion date
2006-10-31
Last updated
2008-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass, Pleural Effusion

Keywords

pleural effusion, coronary artery bypass, heart valve replacement

Brief summary

Pleural effusion is a common complication of cardiac surgery. The aim of this study was to determine the prevalence, characteristics and determinants of clinically significant pleural effusions, defined as those requiring therapeutic pleural drainage.

Detailed description

This was a retrospective cohort study of prevalence and characteristics of patients who had a pleural effusion after coronary artery bypass graft, valve replacement or both procedures. Information was collected on all consecutive patients who underwent CABG surgery and/or valve replacement between January 1, 2004 and December 31, 2005. Demographic information, anthropometric parameters, cardiac and renal function assessments, and comorbid conditions were retrieved from medical files. We also collected data on the type of procedure, whether it was elective or urgent, the number and origin of the grafts, the duration of surgery and of cardiopulmonary bypass and the postoperative complications, including pleural effusions. Clinical presentation and evolution of the effusions as well as pleural fluid characteristics were also studied. Patients were considered to have a clinically significant pleural effusion when they met at least one of the following criteria: need for thoracentesis, a pleural drainage tube or a hospital readmission due to a pleural effusion that occurred within one year of surgery.

Interventions

None listed

Sponsors

Laval University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Coronary artery bypass grafting (CABG) * Valve replacement * Combined CABG and valve replacement * between January 1st, 2004 and December 31st, 2005

Exclusion criteria

* Previous CABG * Pulmonary and/or aortic artery surgery * Heart or lung transplant * Pleural effusion present at the time of surgery

Design outcomes

Primary

MeasureTime frame
Pleural effusion requiring therapeutic drainagewithin the first 12 months after surgery

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026